Trial Details

NOT_YET_RECRUITING
Basic Information
Clinical ID c94
Identifier NCT07184138
Trial Title Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflamatory Bowel Disease (Crohn's and Ulcerative Colitis)
Interventions DRUG: Interleukin-23 Inhibitors (IL-23i)
Participant Information
Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-10-01
Primary Completion Date 2028-10-01
Completion Date 2028-11-01